OpenVSafe by OpenVAERS
Search V-safe

C5R-59572-81255

4 vaccinations 18 coded responses 27 check-ins 18 free-text entries 3 call cases
Sex
Female
Age at first dose
61-65
ZIP prefix
949 / CA
Registered
2021-10-24
Relationship
Self
Race
Multiracial
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-03-17
    Dose 1 — Pfizer-BioNTech
  2. 2021-04-07
    Dose 2 — Pfizer-BioNTech
  3. 2021-10-23
    Dose 3 — Pfizer-BioNTech
  4. 2021-10-24
    Registered in v-safe
  5. 2021-10-24
    Survey response — days 1–6 daily, dose 3
    MedDRA: Injection site pain — Feeling: Fair · Site: Pain · Fever · Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities
    Free text: Arm pain at site of injection
    MedDRA releases: 2024-11 · check-in free text available
  6. 2021-10-25
    Survey response — days 1–6 daily, dose 3
    MedDRA: Mental fatigue — Feeling: Fair · Site: Pain, Redness, Swelling, Itching · Fever · Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities
    Free text: Mental fatigue
    MedDRA releases: 2024-11 · check-in free text available
  7. 2021-10-26
    Survey response — days 1–6 daily, dose 3
    MedDRA: Insomnia, Pain — Feeling: Fair · Site: Pain, Redness, Swelling · Be unable to do your normal daily activities
    Free text: Difficulty sleeping last night due to achiness
    MedDRA releases: 2024-11 · check-in free text available
  8. 2021-10-27
    Health check-in — days 1–6 daily, dose 3
    Feeling: Fair · Fever · Headache, Fatigue or tiredness, Abdominal pain · Be unable to do your normal daily activities
    Adult check-in
  9. 2021-10-28
    Survey response — days 1–6 daily, dose 3
    MedDRA: Lymphadenopathy — Feeling: Fair
    Free text: Swollen lymph node later yesterday
    MedDRA releases: 2024-11 · check-in free text available
  10. 2021-10-29
    Survey response — days 1–6 daily, dose 3
    MedDRA: Arthralgia, Back pain — Feeling: Fair · Site: Pain · Be unable to do your normal daily activities
    Free text: Back and hip pain during the night
    MedDRA releases: 2024-11 · check-in free text available
  11. 2021-10-30
    Health check-in — day 7, dose 3
    Feeling: Good · Rash, not including the immediate area around the injection site
    Adult check-in
  12. 2021-11-06
    Survey response — day 14, dose 3
    MedDRA: Urticaria — Feeling: Good
    Free text: Urticaria
    MedDRA releases: 2024-11 · check-in free text available
  13. 2021-11-13
    Health check-in — day 21, dose 3
    Feeling: Good
    Adult check-in
  14. 2021-11-20
    Health check-in — day 28, dose 3
    Feeling: Good
    Adult check-in
  15. 2021-11-27
    Health check-in — day 35, dose 3
    Feeling: Good
    Adult check-in
  16. 2021-12-04
    Health check-in — day 42, dose 3
    Feeling: Good
    Adult check-in
  17. 2022-01-22
    Health check-in — 3 months, dose 3
    Feeling: Good
    Adult check-in
  18. 2022-04-13
    Dose 4 — Moderna
  19. 2022-04-14
    Survey response — days 1–6 daily, dose 4
    MedDRA: Brain fog — Feeling: Fair · Site: Pain, Swelling · Headache, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activities
    Free text: Cognitive fuzziness
    MedDRA releases: 2024-11 · check-in free text available
  20. 2022-04-15
    Survey response — days 1–6 daily, dose 4
    MedDRA: Condition aggravated, Pre-existing disease — Feeling: Fair · Headache, Rash, not including the immediate area around the injection site · Be unable to do your normal daily activities
    Free text: My angiodema flared up all over my body.
    MedDRA releases: 2024-11 · check-in free text available
  21. 2022-04-16
    Survey response — days 1–6 daily, dose 4
    MedDRA: Angioedema, Pre-existing disease — Feeling: Poor · Rash, not including the immediate area around the injection site · Be unable to do your normal daily activities
    Free text: My angiodema continues to worsen and I had had to increase my dosage of prednisone.
    MedDRA releases: 2024-11 · check-in free text available
  22. 2022-04-17
    Survey response — days 1–6 daily, dose 4
    MedDRA: Angioedema, Pre-existing disease, Unevaluable event — Feeling: Fair · Rash, not including the immediate area around the injection site · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional
    Free text: Systemic reaction (other): I have angiodema. It flared after my booster. I am now taking high dose prednisone to control the flareup. · Healthcare visit (other): Left a message for my doctor Fri aft. Will check in tomorrow with him.
    MedDRA releases: 2024-11 · check-in free text available
  23. 2022-04-17
    Report sent to call center — days 1–6 daily, dose 4
    Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    1 call case(s)
  24. 2022-04-18
    Survey response — days 1–6 daily, dose 4
    MedDRA: Angioedema — Feeling: Good · Rash, not including the immediate area around the injection site
    Free text: Angiodema is responding to increased dosage of prednisone. Will see my specislist doctor on Fri.
    MedDRA releases: 2024-11 · check-in free text available
  25. 2022-04-19
    Survey response — days 1–6 daily, dose 4
    MedDRA: Condition aggravated, Pre-existing disease — Feeling: Good
    Free text: Angiodema flareup has receded.
    MedDRA releases: 2024-11 · check-in free text available
  26. 2022-04-20
    Survey response — day 7, dose 4
    MedDRA: Angioedema, Inflammation, Pre-existing disease — Feeling: Good
    Free text: Slight inflammation due to remaining angiodema flareup
    MedDRA releases: 2024-11 · check-in free text available
  27. 2022-04-27
    Survey response — day 14, dose 4
    MedDRA: Urticaria — Feeling: Fair · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation
    Free text: Continued hives requiring increased dose of prednisone than before the booster.
    MedDRA releases: 2024-11 · check-in free text available
  28. 2022-04-27
    Report sent to call center — day 14, dose 4
    Get care from a doctor or other healthcare professional
    Telehealth, virtual health, or email health consultation · 1 call case(s)
  29. 2022-04-28
  30. 2022-04-28
    Call successful
    Does not wish to fill out VAERS report
  31. 2022-05-04
    Health check-in — day 21, dose 4
    Feeling: Fair
    Adult check-in
  32. 2022-05-11
    Survey response — day 28, dose 4
    MedDRA: Angioedema, Pre-existing disease, Scar, Vascular rupture — Feeling: Fair · Be unable to do your normal daily activities
    Free text: My angiodema flared after the booster. It has worsened in the last week. I have scars in my legs from popped blood vessels.
    MedDRA releases: 2024-11 · check-in free text available
  33. 2022-05-18
    Health check-in — day 35, dose 4
    Feeling: Fair
    Adult check-in
  34. 2022-05-25
    Survey response — day 42, dose 4
    MedDRA: Dermatitis, Vasculitis — Feeling: Fair · Be unable to do your normal daily activities
    Free text: Skin inflammation that affected blood vessels. Received a punch biopsy for vasculitis yesterday. Waiting for results.
    MedDRA releases: 2024-11 · check-in free text available
  35. 2022-07-15
    Survey response — 3 months, dose 4
    MedDRA: Systemic lupus erythematosus, Unevaluable event, Urticarial vasculitis — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit
    Free text: Symptoms: Been diagnosed with urticarial vasculitis. Being treated for Lupus. · Healthcare visit (other): Referred to dermatologist and rheumatologist at (b)(6).
    MedDRA releases: 2024-11 · check-in free text available
  36. 2022-07-15
    Report sent to call center — 3 months, dose 4
    Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    Telehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
  37. 2022-07-18
  38. 2022-10-12
    Survey response — 6 months, dose 4
    MedDRA: Connective tissue disorder, Dry eye, Dry mouth, Nodal arrhythmia, Supraventricular tachycardia — Feeling: Fair · Be unable to do your normal daily activities
    Free text: Diagnosis of Unspecified Connective Tissue Disorder. Increased severity of dry eyes and dry mouth. Started on Hydroxychloroquine. Arythemia Nodosum. Tachycardia (SVT).
    MedDRA releases: 2024-11 · check-in free text available

Vaccinations

DoseDateManufacturerCo-administered
12021-03-17Pfizer-BioNTech No
22021-04-07Pfizer-BioNTech No
32021-10-23Pfizer-BioNTech No
42022-04-13Moderna No

Call center

3 call center cases

2 successful · 1 unsuccessful

See the call center timeline

Free text

Release 10 — days 1–6 daily, dose 3

2021-10-24

Systemic reaction (other): Arm pain at site of injection

2021-10-25

Systemic reaction (other): Mental fatigue

2021-10-26

Systemic reaction (other): Difficulty sleeping last night due to achiness

2021-10-28

Systemic reaction (other): Swollen lymph node later yesterday

2021-10-29

Systemic reaction (other): Back and hip pain during the night

Release 10 — day 14, dose 3

2021-11-06

Symptoms: Urticaria

Release 11 — days 1–6 daily, dose 4

2022-04-14

Systemic reaction (other): Cognitive fuzziness

2022-04-15

Systemic reaction (other): My angiodema flared up all over my body.

2022-04-16

Systemic reaction (other): My angiodema continues to worsen and I had had to increase my dosage of prednisone.

2022-04-17

Systemic reaction (other): I have angiodema. It flared after my booster. I am now taking high dose prednisone to control the flareup.
Healthcare visit (other): Left a message for my doctor Fri aft. Will check in tomorrow with him.

2022-04-18

Systemic reaction (other): Angiodema is responding to increased dosage of prednisone. Will see my specislist doctor on Fri.

2022-04-19

Systemic reaction (other): Angiodema flareup has receded.

Release 11 — day 7, dose 4

2022-04-20

Systemic reaction (other): Slight inflammation due to remaining angiodema flareup

Release 11 — day 14, dose 4

2022-04-27

Symptoms: Continued hives requiring increased dose of prednisone than before the booster.

Release 11 — day 28, dose 4

2022-05-11

Symptoms: My angiodema flared after the booster. It has worsened in the last week. I have scars in my legs from popped blood vessels.

Release 11 — day 42, dose 4

2022-05-25

Symptoms: Skin inflammation that affected blood vessels. Received a punch biopsy for vasculitis yesterday. Waiting for results.

Release 12 — 3 months, dose 4

2022-07-15

Symptoms: Been diagnosed with urticarial vasculitis. Being treated for Lupus.
Healthcare visit (other): Referred to dermatologist and rheumatologist at (b)(6).
redacted (b)(6)

Release 12 — 6 months, dose 4

2022-10-12

Symptoms: Diagnosis of Unspecified Connective Tissue Disorder. Increased severity of dry eyes and dry mouth. Started on Hydroxychloroquine. Arythemia Nodosum. Tachycardia (SVT).

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
HCVOUnevaluable event · · ✓
SDAngioedema · · ✓
SDConnective tissue disorder · · ✓
SDDermatitis · · ✓
SDDry eye · · ✓
SDDry mouth · · ✓
SDNodal arrhythmia · · ✓
SDPre-existing disease · · ✓
SDScar · · ✓
SDSupraventricular tachycardia · · ✓
SDSystemic lupus erythematosus · · ✓
SDUrticaria · · ✓
SDUrticarial vasculitis · · ✓
SDVascular rupture · · ✓
SDVasculitis · · ✓
SROAngioedema · · ✓
SROArthralgia · · ✓
SROBack pain · · ✓
SROBrain fog · · ✓
SROCondition aggravated · · ✓
SROInflammation · · ✓
SROInjection site pain · · ✓
SROInsomnia · · ✓
SROLymphadenopathy · · ✓
SROMental fatigue · · ✓
SROPain · · ✓
SROPre-existing disease · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release